EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Left prefrontal intermittent theta-burst stimulation therapy for major depressive disorder: A real-world, multisite observational study in Japan

Yoshihiro Noda, Ryota Osawa, Yuya Takeda, Kyoshiro Fujii, Yuka Saijo, Taku Kajiya, Kana Takeishi, Sotaro Moriyama, Takashi Saeki, Shinichiro Nakajima, Ryosuke Kitahata

Journal of Affective Disorders · 2025-04 · 375 · 316-323

DOI: 10.1016/j.jad.2025.01.131 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Affective Disorders, 2025-04. Verfasst von Yoshihiro Noda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shinjuku-Yoyogi Mental Lab Clinic, Tokyo, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Department of Psych…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Transcranial Magnetic Stimulation, Prefrontal Cortex, Theta Rhythm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Watanabe Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although approved for treatment in 2018, the effectiveness of intermittent theta-burst stimulation (iTBS) in a real-world setting remains inadequately studied. This observational study investigated the real-world use of iTBS, a usual medical practice for depression, factors influencing its effectiveness, and differences in effectiveness between 600 and 1200 pulses. METHODS: Data from patients who received iTBS therapy for depression at four private clinics between January 2021 and April 2024 were extracted. Patients were assessed using the 17-item Hamilton Depression Rating Scale at baseline and after treatment completion. Correlation and multiple regression analyses were performed to investigate clinico-demographic factors and stimulation parameters associated with iTBS effectiveness. Safety was assessed using all relevant data, and effectiveness was evaluated using eligible samples. RESULTS: Among 538 patients meeting eligibility criteria for effectiveness evaluation (mean age 40.8 ± 13.8 years, 44.1 % women), 63 completed iTBS with 600 pulses, and 475 completed iTBS with 1200 pulses. Overall response and remission rates were 69.1 % and 53.7 %, respectively, with no significant difference in effectiveness between iTBS-600 and iTBS-1200. Multiple regression analysis indicated fewer depressive episodes (β = -0.103, t = -2.080, p = 0.038) and more treatment sessions (β = 0.134, t = 3.155, p = 0.002) may have contributed to the positive effect of iTBS therapy. The most common adverse event was stimulation site pain. No severe adverse events, such as seizure induction or manic switch, were observed. CONCLUSION: The results suggest the highly favorable effectiveness of iTBS therapy for major depressive disorder in real-world settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderTranscranial Magnetic StimulationPrefrontal CortexTheta RhythmHumansFemaleMaleAdultMiddle AgedJapanTreatment Outcome

Stichwörter der Autor:innen

Major depressive disorderReal-world studyTranscranial magnetic stimulation registry studytheta-burst stimulation

Autor:innen und Institutionen

  • Shinjuku-Yoyogi Mental Lab Clinic, Tokyo, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Department of Psychiatry, International University of Health and Welfare, Mita Hospital,…
  • Tokyo Yokohama TMS Clinic, Minato-Tokyo, Tokyo, Japan; Tokyo Yokohama TMS Clinic, Kosugi-Kanagawa, Kawasaki, Japan.
  • Shinjuku-Yoyogi Mental Lab Clinic, Tokyo, Japan.
  • Tokyo Yokohama TMS Clinic, Kosugi-Kanagawa, Kawasaki, Japan.
  • Tokyo Yokohama TMS Clinic, Minato-Tokyo, Tokyo, Japan.
  • Shinjuku-Yoyogi Mental Lab Clinic, Tokyo, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Watanabe Foundation
  • Inter Reha

Zitieren

APA

Noda, Y., Osawa, R., Takeda, Y., Fujii, K., Saijo, Y., Kajiya, T., Takeishi, K., Moriyama, S., Saeki, T., Nakajima, S., & Kitahata, R. (2025). Left prefrontal intermittent theta-burst stimulation therapy for major depressive disorder: A real-world, multisite observational study in Japan. Journal of Affective Disorders, 375, 316-323. https://doi.org/10.1016/j.jad.2025.01.131

Vancouver

Noda Y, Osawa R, Takeda Y, Fujii K, Saijo Y, Kajiya T, et al. Left prefrontal intermittent theta-burst stimulation therapy for major depressive disorder: A real-world, multisite observational study in Japan. Journal of Affective Disorders. 2025;375:316-323. doi:10.1016/j.jad.2025.01.131

BibTeX
@article{Noda2025,
  author = {Noda, Yoshihiro and Osawa, Ryota and Takeda, Yuya and Fujii, Kyoshiro and Saijo, Yuka and Kajiya, Taku and Takeishi, Kana and Moriyama, Sotaro and Saeki, Takashi and Nakajima, Shinichiro and Kitahata, Ryosuke},
  title = {Left prefrontal intermittent theta-burst stimulation therapy for major depressive disorder: A real-world, multisite observational study in Japan},
  journal = {Journal of Affective Disorders},
  year = {2025},
  volume = {375},
  pages = {316--323},
  doi = {10.1016/j.jad.2025.01.131}
}
Kostenlos starten →